Skip to content

Ginkgo Bioworks DNA Current ratio

Current ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.5×-0.2×
Charles River Laboratories logo
Charles River LaboratoriesCRL
1.4×-0.1×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
14.1×+3.9×
TEC
Bio-TechneTECH
4.5×+0.8×
Azenta logo
AzentaAZTA
2.8×
Regenxbio logo
RegenxbioRGNX
2.6×-0.3×

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

Based on the most recent quarter.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's current ratio?
Ginkgo Bioworks (DNA) reported current ratio of 5.2× in Q1 2026.
How has Ginkgo Bioworks's current ratio changed year-over-year?
Ginkgo Bioworks's current ratio increased by 5.5% year-over-year, from 4.9× to 5.2×.
What is the long-term trend for Ginkgo Bioworks's current ratio?
Over 5 years (2020 to 2025), Ginkgo Bioworks's current ratio has grown at a -3.3% compound annual growth rate (CAGR), from 5.8× to 4.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.